850 AIDS patients awaiting treatment in 10 states finally get access to HIV medication.

There is some good news for concerned citizen activists:


Heinz Family Philanthropies, Welvista and Abbott Announce Solution to Help Patients on State ADAP Waiting Lists for No-Cost HIV Medications


Program set to help the more than 850 patients in 10 states waiting for HIV treatment

PITTSBURGH, May 7 /PRNewswire-USNewswire/ -- Heinz Family Philanthropies, Welvista and Abbott today announced a solution that begins to address the needs of patients waiting for access to HIV medications. These patients are on waiting lists in 10 states for the AIDS Drug Assistance Program (ADAP), which provides help and no-cost medication for those patients who cannot afford their medication, but do not qualify for Medicaid assistance.

In addition to the collaboration with Heinz Family Philanthropies, Abbott is providing a grant to Welvista, a nonprofit organization that fills prescriptions for patients who are uninsured and underinsured. This grant will help provide for a one-year program to help any patient on a state ADAP waiting list who needs an Abbott HIV medication. Abbott, the global health care company, makes protease inhibitors that are important components of many HIV combination treatment regimens.

The program eliminates all enrollment forms for these patients. Enrollment is virtually automatic for anyone certified on an ADAP waiting list and can provide direct access to no-cost Abbott HIV medications through Welvista. Patients who are on ADAP waiting lists and need to access this solution to receive their Abbott medications can request their state ADAP contact Welvista. If need exists after one year, the program may be extended.

The solution was developed by the three organizations in response to a call for help from NASTAD (the National Alliance of State and Territorial AIDS Directors) to find ways to clear the waiting lists and make enrollment simple for patients. The ADAP waiting lists have increased exponentially in some areas due to state budget crises.

This is a national initiative designed to help patients in any state. However, the states that currently have ADAP waiting lists include Idaho, Iowa, Kentucky, Montana, North Carolina, South Carolina, South Dakota, Tennessee, Utah and Wyoming.

"Abbott supports extensive patient assistance programs for people taking our HIV medications and this solution with the Heinz Foundation and Welvista is another important way to efficiently help patients in need obtain their antiretroviral therapy at no cost," said Thad Smith, director of Patient Access Programs, Abbott.

"Heinz and Welvista have been quietly creating Rx solutions around the United States. Helping those with HIV/AIDS who are in need of immediate medications is critically important to us. This solution, in conjunction with our partner Abbott, is a great example of how business, philanthropy and nonprofits can create sustainable, long term solutions together that actually work and help people. Our goal is a simple one -- help every eligible person suffering from HIV/AIDS to gain access to free medications so they never fear they will prematurely enter a long term care facility because they could not get the medicines they need. This solution begins to address this problem and we invite other private sector partners to support this effort to broaden the reach to more patients, "said Jeffrey Lewis, President of the Heinz Family Philanthropies.

"AIDS Drug Assistance Programs across the nation are experiencing the worst funding shortfall in many years. Through these efforts, eligible clients currently on the waiting list for ADAPs will be able to obtain Abbott's medications through Welvista," said Ken Trogdon, Chief Executive Officer of Welvista. "Welvista will be working with states across the nation to become their pharmacy connection in providing these patients with Abbott's HIV medications. It is our hope that other private sector partners will join us to further expand the medication reach to even more patients."

was cut off some weeks ago.

Pretty sad.

Hopefully more states won't be so cruel.